Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gampe

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|March 30, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonistsWilliam J Zuercher, Richard G Buckholz, Nino Campobasso, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical DevelopmentJeffrey M Axten, Stuart P Romeril, Arthur Shu, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 14, 2006
Crystallization of protein-ligand complexesAnne M Hassell, Gang An, Randy K Bledsoe, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|March 30, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonistsWilliam J Zuercher, Richard G Buckholz, Nino Campobasso, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical DevelopmentJeffrey M Axten, Stuart P Romeril, Arthur Shu, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 14, 2006
Crystallization of protein-ligand complexesAnne M Hassell, Gang An, Randy K Bledsoe, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Pageof 3